Plasma levels of S100A4 in portopulmonary hypertension

References

• Colle IO, Moreau R, Godinho E, Belghiti J, Ettori F, Cohen-Solal A, Mal H, Bernuau J, Marty J, Lebrec D, Valla D, Durand F. 2003. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 37:401–409.
   PubMed Web of Science ®Google Scholar
• Flatmark K, Maelandsmo GM, Mikalsen SO, Nustad K, Varaas T, Rasmussen H, Meling GI, Fodstad ø, Paus E. 2004. Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum. Tumour Biol 25:31–40.
   Google Scholar
• Garrett SC, Varney KM, Weber DJ, Bresnick AR. 2006. S100A4, a mediator of metastasis. J Biol Chem 281:677–680.
   PubMed Web of Science ®Google Scholar
• Greenway S, van Suylen RJ, Du Marchie Sarvaas G, Kwan E, Ambartsumian N, Lukanidin E, Rabinovitch M. 2004. S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Am J Pathol 164:253–262.
   PubMedGoogle Scholar
• Hintze J. NCSS and PASS 2005. Kaysville, Utah: Number Cruncher Statistical Systems, 2004.
   Google Scholar
• Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS Jr, Fallon MB for the Pulmonary Vascular Complications of Liver Disease Study Group. 2008. Clinical risk factors for portopulmonary hypertension. Hepatology 48:196–203.
   PubMed Web of Science ®Google Scholar
• Kawut SM, Taichman DB, Ahya VN, Kaplan S, Archer-Chicko CL, Kimmel SE, Palevsky HI. 2005. Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transpl 11:1107–1111.
   PubMed Web of Science ®Google Scholar
• Klingelhöfer J, Senolt L, Baslund B, Nielsen GH, Skibshøj I, Pavelka K, Neidhart M, Gay S, Ambartsumian N, Hansen BS, Petersen J, Lukanidin E, Grigorian M. 2007. Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 56:779–789.
   PubMed Web of Science ®Google Scholar
• Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, Pardo M Jr, Marotta P, Uemoto S, Stoffel MP, Benson JT. 2004. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 10:174–182.
   PubMed Web of Science ®Google Scholar
• Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. 2006. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology 44:1502–1510.
   PubMed Web of Science ®Google Scholar
• Lawson WE, Polosukhin VV, Zoia O, Stathopoulos GT, Han W, Plieth D, Loyd JE, Neilson EG, Blackwell TS. 2005. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med 171:899–907.
   PubMed Web of Science ®Google Scholar
• Merklinger SL, Wagner RA, Spiekerkoetter E, Hinek A, Knutsen RH, Kabir MG, Desai K, Hacker S, Wang L, Cann GM, Ambartsumian NS, Lukanidin E, Bernstein D, Husain M, Mecham RP, Starcher B, Yanagisawa H, Rabinovitch M. 2005. Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension. Circ Res 97:596–604.
   Google Scholar
• Roberts KE, Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, Tighiouart H, Knowles JA, Rabinowitz D, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Kawut SM for the PVCLD Study Group. 2009. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Resp Crit Care Med (in press).
   Google Scholar
• Rygiel KA, Robertson H, Marshall HL, Pekalski M, Zhao L, Booth TA, Jones DE, Burt AD, Kirby JA. 2008. Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest 88:112–123.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A. 2004. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43(12 Suppl. S):5S–12S.
   PubMed Web of Science ®Google Scholar
• Sussman N, Kaza V, Barshes N, Stribling R, Goss J, O’Mahony C, Zhang E, Vierling J, Frost A. 2006. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series. Am J Transplant 6:2177–2182.
   PubMed Web of Science ®Google Scholar
• Yanagisawa H, Davis EC, Starcher BC, Ouchi T, Yanagisawa M, Richardson JA, Olson EN. 2002. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415:168–171.
   PubMed Web of Science ®Google Scholar